<DOC>
	<DOCNO>NCT02092935</DOCNO>
	<brief_summary>The purpose research study evaluate safety effectiveness new oral antibiotic call SMT19969 treat C. difficile Infection ( CDI ) .</brief_summary>
	<brief_title>A Study SMT19969 Compared With Vancomycin Treatment Clostridium Difficile-Associated Diarrhoea ( CDAD )</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Informed consent Clinical diagnosis CDAD plus laboratory diagnostic test No 24 hrs antimicrobial treatment current CDAD episode No 3 episode CDAD prior 12 month No previous episode CDAD within 30 day study enrollment Female subject childbearing potential must use adequate contraception Lifethreatening fulminant colitis Concurrent use antibiotic treatment CDAD History inflammatory bowel disease ( ulcerative colitis , Crohn 's disease ) Participation Clinical research study within one month screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>CDAD</keyword>
	<keyword>Clostridium Difficile</keyword>
</DOC>